| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/01/2004 | WO2002066606A3 Polynucleotides encoding a novel glycine receptor alpha subunit expressed in the gastrointestinal tract, hgra4, and splice variant thereof |
| 04/01/2004 | WO2002064631A3 T1r taste receptors and genes encoding same |
| 04/01/2004 | WO2002059377A3 Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer |
| 04/01/2004 | WO2002058637A9 Compositions and methods for diagnosis of neuropsychiatric disorders |
| 04/01/2004 | WO2002057299A9 Vegfr-3 binding peptides and their use for inhibiting angiogenesis |
| 04/01/2004 | WO1990001943A8 Treatment of myeloid leukemias by inducing terminal differentiation with interleukin-6 |
| 04/01/2004 | US20040064858 Spression of specific classes of soybean seed protein |
| 04/01/2004 | US20040064856 Regulatory sequences for controlling heterologous gene expression in plants; tissue engineering |
| 04/01/2004 | US20040064855 Production of lysosomal enzymes in plants by transient expression |
| 04/01/2004 | US20040064854 Expression vector coding prunin (PRU) protein for transformation and generation of plants and seed with enhanced storage capacity |
| 04/01/2004 | US20040064850 Antifungal polypeptide and methods for controlling plant pathogenic fungi |
| 04/01/2004 | US20040064849 Use of genes encoding membrane transporter pumps to stimulate the production of secondary metabolites in biological cells |
| 04/01/2004 | US20040064847 Transgenic plants exhibiting resistance to a spectrum of pathogens |
| 04/01/2004 | US20040064841 Transgenic swine which produce growth factors which facilitate piglet development and decrease mortality; veterinary medicine |
| 04/01/2004 | US20040063955 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines |
| 04/01/2004 | US20040063924 Comprises nucleotide sequences coding membrane proteins for treatment diagnosis and prevention of cell proliferative, inflammatory, autoimmune, nervous system, cardiovascular and developmental disorders |
| 04/01/2004 | US20040063921 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/01/2004 | US20040063919 Freeze drying egg white; using cationic ion exchange resin |
| 04/01/2004 | US20040063918 Genetic engineering using azide modified amino acid; sulfating, phosphorylation, glycosylation |
| 04/01/2004 | US20040063917 Modified erythropoietin (epo) with reduced immunogenicity |
| 04/01/2004 | US20040063915 Comprises protein polymers coated with metal for preparation of tubulin-based cytoskeltal fibers |
| 04/01/2004 | US20040063911 Genetic engineering; using glycosyltransferases |
| 04/01/2004 | US20040063910 Comprises cytokine fusion protein receptor domain for diagnosis and treatment of cell proliferative and vision disorders |
| 04/01/2004 | US20040063909 Comprises nucleotide sequences coding membrane proteins for treatment and diagnosis cell proliferative, inflammatory, autoimmune and nervous system disorders |
| 04/01/2004 | US20040063908 Comprises genetically engineered hemophilus adherence and penetration (HAP) proteins for treatment and prevention of influenza; immunotherapy |
| 04/01/2004 | US20040063907 Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 04/01/2004 | US20040063906 Peptide nucleic acid sequences; antibodies for controlling disease; bactericides, viricides |
| 04/01/2004 | US20040063905 Armed peptides |
| 04/01/2004 | US20040063790 By administering an organic peptidomimetic vibronectin receptor alpha v beta 3 antagonist of given structures |
| 04/01/2004 | US20040063653 Devoid of protease, reverse transcriptase, RNase H and integrase activity |
| 04/01/2004 | US20040063652 Introducing multiple nucleic acid molecules simultaneously without deletereous effects; controlling level of expression |
| 04/01/2004 | US20040063639 Storage stable buffered liquid and lyophilized materials |
| 04/01/2004 | US20040063638 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/01/2004 | US20040063635 Recombinant human albumin fusion proteins with long-lasting biological effects |
| 04/01/2004 | US20040063634 Modified kertinocyte growth factor (kgf) with reduced immunogenicity |
| 04/01/2004 | US20040063633 Interleukin-18 inducing agent |
| 04/01/2004 | US20040063632 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 04/01/2004 | US20040063631 Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu amino acid sequence |
| 04/01/2004 | US20040063630 Enhanced diuresis with reduced side effects; recombinant or synthetic human B-type peptide |
| 04/01/2004 | US20040063621 Heterocarpine, a human ghrh-binding protein |
| 04/01/2004 | US20040063618 Peptide nucleic acids having improved uptake and tissue distribution |
| 04/01/2004 | US20040063617 Expressing a nucleic acid encoding protein selected from lactoferrin protein and lysozyme protein in a monocot seed; isolating protein from the seed, combining with carrier diluent to provide formulation for oral administration |
| 04/01/2004 | US20040063201 Controlling lineage development in an in vitro human tissue system for bone marrow transplantation |
| 04/01/2004 | US20040063190 Preparation and usage of plasmodium fusion antigen |
| 04/01/2004 | US20040063188 Kit for treating gastrointestinal tract |
| 04/01/2004 | US20040063186 Vectors and methods for recombinant protein expression |
| 04/01/2004 | US20040063180 Comprises nucleotide sequences coding lysine biosynthetic polypeptide for transforming coryneform bacteria and fermentation of lysine; animal feeds and medicine |
| 04/01/2004 | US20040063179 Novel potassium channel molecules and uses therefor |
| 04/01/2004 | US20040063176 Compositions, methods and kits relating to remodel |
| 04/01/2004 | US20040063173 Hsp70 peptide stimulating natural killer (nk) cell activity and uses thereof |
| 04/01/2004 | US20040063145 Transcription factor comprising bromodomain for diagnosis and treatment of leukemia |
| 04/01/2004 | US20040063140 Methods for diagnosis of cancer using erbB-3 |
| 04/01/2004 | US20040063134 Novel isoforms of human pregnancy-associated protein-E |
| 04/01/2004 | US20040063132 Comprises uterine myometrium lieomya receptor (UMLR) protein for diagnosis, prevention and treatment of cell proliferative disorders; antitumor agents |
| 04/01/2004 | US20040063131 Comprises neuroendocrine-specific proteins-like polypeptides (NSPLP) for diagnosis, prevention and treatment of neurodegenerative and cell proliferative diseases |
| 04/01/2004 | US20040063128 20 Human secreted proteins |
| 04/01/2004 | US20040063127 Comprises nuclelotide sequences coding cytokine for diagnosis, prevention and treatment of infection, hepatitis, nephritis, cancer and autoimmune diseases |
| 04/01/2004 | US20040063125 Transgenic cells coding membrane protein which controls intracellular hydrogen ion concentration for identifying modulators for treatment of diabetes |
| 04/01/2004 | US20040063123 Using allelic mutation in defensin genes to diagnose and prognose oral disorders |
| 04/01/2004 | US20040063110 Novel probes for the detection of mycobacteria |
| 04/01/2004 | US20040063101 Comprises nucleotide sequences coding cancer/testis (CT) antigen for diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy |
| 04/01/2004 | US20040063095 gM-negative EHV-mutants |
| 04/01/2004 | US20040063093 Recombinant feline coronavirus S proteins |
| 04/01/2004 | US20040063092 Immunoassays for anti-HCV antibodies |
| 04/01/2004 | US20040062810 Removal blockage in blood vessels; mixture of angiogenesis inhibitor and polymer |
| 04/01/2004 | US20040062793 Protein network; wound healing agent |
| 04/01/2004 | US20040062775 Nucleotide sequences; veterinary medicine; vaccine |
| 04/01/2004 | US20040062774 Multiple epitope immunoglobulin for prevention and/or treatment of mastitis; bactericides |
| 04/01/2004 | US20040062772 Attenuated live neospora vaccine |
| 04/01/2004 | US20040062771 Clostridial toxin disease therapy |
| 04/01/2004 | US20040062770 Modulators of fgl2 prothrombinase |
| 04/01/2004 | US20040062769 Identification of the domain of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) that mediates adhesion to chondroitin sulfate A |
| 04/01/2004 | US20040062767 Genetic engineering; synergistic mixture of antibodies |
| 04/01/2004 | US20040062761 Nucleic acid and corresponding protein entitled 151P3D4 useful in treatment and detection of cancer |
| 04/01/2004 | US20040062752 Genetic engineered polynucleotide; antihemophilic factor; in situ administering to liver |
| 04/01/2004 | US20040062749 Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity |
| 04/01/2004 | DE10244457A1 Verfahren zur rationalen Mutagenese von alpha/beta T-Zell Rezeptoren und entsprechend mutierte MDM2-Protein spezifische alpha/beta T-Zell Rezeptoren A process for the rational mutagenesis of alpha / beta T-cell receptors and corresponding mutant MDM2 protein specific alpha / beta T-cell receptors |
| 04/01/2004 | CA2833202A1 Compstatin analogs with improved activity |
| 04/01/2004 | CA2767235A1 Peptides and related molecules that modulate nerve growth factor activity |
| 04/01/2004 | CA2538719A1 Gd2 ligands |
| 04/01/2004 | CA2502690A1 Compstatin analogs with improved activity |
| 04/01/2004 | CA2499995A1 Compositions and methods for treatment of herpesvirus infections |
| 04/01/2004 | CA2499643A1 Lentiviral vector-mediated gene transfer and uses thereof |
| 04/01/2004 | CA2499625A1 Methods of increasing platelet and hematopoietic stem cell production |
| 04/01/2004 | CA2499482A1 Ammonia-oxidizing bacteria and methods of using and detecting the same |
| 04/01/2004 | CA2499467A1 Methods for increasing the production of a recombinant polypeptide from a host cell |
| 04/01/2004 | CA2499404A1 Recovery of recombinant human parainfluenza virus type 2 (hpiv2) from cdna and use of recombinant hpiv2 in immunogenic compositions and as vectors to elicit immune responses against piv and other human pathogens |
| 04/01/2004 | CA2499386A1 High titer recombinant aav production |
| 04/01/2004 | CA2498896A1 Ihnv g protein for immune stimulation |
| 04/01/2004 | CA2498886A1 Process for decreasing aggregate levels of pegylated protein |
| 04/01/2004 | CA2498604A1 Live antenuated parasite vaccine |
| 04/01/2004 | CA2498325A1 Prophylactic and therapeutic hiv aptamers |
| 04/01/2004 | CA2497937A1 Nuclear factor of activated t cells receptor |
| 04/01/2004 | CA2497635A1 Transgenic expression cassettes for expressing nucleic acids in non-reproductive flower tissues of plants |
| 04/01/2004 | CA2496687A1 Ghrh analogues |
| 04/01/2004 | CA2486280A1 Identification of a phage associated lytic enzyme to rapidly and specifically detect and kill bacillus anthracis |
| 04/01/2004 | CA2483624A1 Improved raav expression systems for genetic modification of specific capsid proteins |
| 04/01/2004 | CA2474680A1 Method for analyzing organelle-localized protein and material for analysis |
| 04/01/2004 | CA2443463A1 Concentrate of a factor viii:c-containing von willebrand factor and the process relating thereto |
| 03/31/2004 | EP1403640A1 Peptide-immobilized baseboard and method of assaying target protein using the same |